Anika Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
1,017
across all filing types
Latest filing
2026-06-01
Proxy Solicitation & In…
Country
US
United States of America
Listing
US
ANIK
Anika Therapeutics, Inc. is a global joint preservation company focused on developing, manufacturing, and marketing solutions for early intervention orthopedic care. The company provides a range of therapeutic products and regenerative solutions designed to treat degenerative orthopedic diseases, traumatic conditions, joint pain, and arthritis. Its portfolio, which utilizes technologies such as hyaluronic acid, aims to restore joint function and enable patients to maintain an active lifestyle. Key products include the Integrity™ Implant System, a regenerative scaffold for tendon augmentation. Anika partners with medical professionals to deliver treatments across the continuum of joint care.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-06-01 | English | |
| FORM 10-Q | 2026-04-30 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| 8-K - Anika Therapeutics, Inc. (0000898437) (Filer) | 2026-04-29 | English | |
| ARS | 2026-04-28 | English | |
| DEFA14A | 2026-04-28 | English |
Browse filings by year
26 years- 2026 19 filings
- 2025 45 filings
- 2024 54 filings
- 2023 55 filings
- 2022 50 filings
- 2021 48 filings
- 2020 60 filings
- 2019 47 filings
- 2018 46 filings
- 2017 53 filings
- 2016 43 filings
- 2015 39 filings
- 2014 38 filings
- 2013 47 filings
- 2012 34 filings
- 2011 37 filings
- 2010 29 filings
- 2009 31 filings
- 2008 40 filings
- 2007 26 filings
- 2006 51 filings
- 2005 38 filings
- 2004 41 filings
- 2003 30 filings
- 2002 11 filings
- 2001 5 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47920166 | DEFA14A | 2026-06-01 | English | ||
| 46301618 | FORM 10-Q | 2026-04-30 | English | ||
| 46300927 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 38532341 | 8-K - Anika Therapeutics, Inc. (0000898437) (Filer) | 2026-04-29 | English | ||
| 46301296 | ARS | 2026-04-28 | English | ||
| 46301379 | DEFA14A | 2026-04-28 | English | ||
| 46301368 | DEF 14A | 2026-04-28 | English | ||
| 46301768 | Major Shareholding Notification 2026 | 2026-03-26 | English | ||
| 33016566 | 4 - Anika Therapeutics, Inc. (0000898437) (Issuer) | 2026-03-23 | English | ||
| 32968839 | 4 - Anika Therapeutics, Inc. (0000898437) (Issuer) | 2026-03-18 | English | ||
| 32968827 | 4 - Anika Therapeutics, Inc. (0000898437) (Issuer) | 2026-03-18 | English | ||
| 32968821 | 4 - Anika Therapeutics, Inc. (0000898437) (Issuer) | 2026-03-18 | English | ||
| 32968819 | 4 - Anika Therapeutics, Inc. (0000898437) (Issuer) | 2026-03-18 | English | ||
| 32883580 | 10-K - ANIKA THERAPEUTICS, INC. (0000898437) (Filer) | 2026-03-02 | English | ||
| 32883567 | 8-K - ANIKA THERAPEUTICS, INC. (0000898437) (Filer) | 2026-02-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Anika Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33997/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33997 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33997 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33997 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33997}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Anika Therapeutics, Inc. (id: 33997)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.